Searchable abstracts of presentations at key conferences in endocrinology

ea0081p709 | Reproductive and Developmental Endocrinology | ECE2022

Serum testosterone mirrors inflammation parameteres in females admitted with covid-19 disease

Francesca Birtolo Maria , Vena Walter , Pizzocaro Alessandro , Jaafar Simona , Ciafardini Antea , Brunetti Alessandro , Pigni Stella , Mazziotti Gherardo , Lania Andrea

Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is showing a rapid and continuous evolution in terms of new waves, the spread of variants and the evidence of reinfections. The growing heterogeneity of clinical presentation requires the identification of underlying pathogenic mechanisms to allow a better risk stratification. Previous studies analysed the role of sex hormones in disease severity demonstrating in male patients the association of...

ea0081oc8.1 | Oral Communications 8: Calcium and Bone | ECE2022

Effectiveness of anti-resorptive drugs on risk of vertebral fractures in women receiving aromatase inhibitors: a prospective study in real-life clinical practice

Mazziotti Gherardo , Vena Walter , Pigni Stella , Carrone Flaminia , Pedersini Rebecca , Cosentini Deborah , Torrisi Rosalba , Birtolo Maria Francesca , Maida Giulia , Berruti Alfredo , Lania Andrea

Bone loss is a frequent complication of aromatase inhibitors (AIs) therapy in women with breast cancer. Bone-active drugs are effective in protecting the skeleton from detrimental actions of AIs. However, bone mineral density (BMD) was the primary end-point in most of published studies, whereas data on fractures were scant and mainly limited to denosumab. In this prospective study, we investigated the effects of denosumab, oral bisphosphonates and intravenous zoledronate on ri...

ea0093oc16 | Oral communication 3: Adrenal Tumors and Neuroendocrine Tumors | EYES2023

Bone fragility in well-differentiated gastroenteropancreatic-neuroendocrine tumors: Results from a retrospective two-centered study

Brunetti Alessandro , Jaafar Simona , Chiardi Isabella , Cellini Miriam , Salcuni Antonio Stefano , Pigni Stella , Lavezzi Elisabetta , Lania Andrea , Mazziotti Gherardo , Vescini Fabio

Background: Patients affected by gastroenteropancreatic-neuroendocrine tumors (GEP-NETs) present an increased risk of bone fragility due to several factors, such as bone metastases, vitamin D deficiency, hormonal secretion, medical and surgical treatments. Although patients with well-differentiated GEP-NETs generally present a long life-expectancy, occurrence of fragility fractures could significantly impair quality of life.Objectives: The study aims to ...

ea0099p252 | Calcium and Bone | ECE2024

Role of variants of uncertain significance in determining bone fragility or low bone mineral density in adults: A multicenter study

Carrara Silvia , Vai Silvia , Mihalich Alessandra , Blasio Anna Di , Ponti Emanuela , Guabello Gregorio , Guarnieri Vito , Pigni Stella , Lania Andrea , Mazziotti Gherardo , Corbetta Sabrina

Osteoporosis causes bone fragility usually affecting the elderly. Genetic susceptibility plays a crucial role in determining the risk of fragility fractures and is involved in early-onset osteoporosis. When fragility fractures or low bone mineral density (BMD) occur in young adults without evident secondary osteoporosis, an underlying monogenetic bone disease should be assessed. The list of genes related to low BMD and their mutations is increasing. Nevertheless, little is kno...

ea0099ep251 | Pituitary and Neuroendocrinology | ECE2024

Diagnostic challenges in cyclic cushing’s syndrome: a rare case due to ectopic acth secretion by lung carcinoid

Colle Roberto , Pigni Stella , Jaafar Simona , Cristofolini Giacomo , Francesca Birtolo Maria , Lavezzi Elisabetta , Bottoni Edoardo , Uccella Silvia , Mazziotti Gherardo , Lania Andrea

Introduction: Cyclic Cushing’s syndrome (cCS) is a rare condition characterized by periods of excessive cortisol secretion (peaks), alternating with phases of eucortisolism (through). In most cases, cCS is caused by an ACTH-secreting pituitary tumor, while only few cases of cyclic ectopic ACTH secretion (cEAS) have been described.Case presentation: In February 2023, a 58-year-old woman was referred to our Endocrine Unit due to a 10-year history of r...

ea0081p305 | Calcium and Bone | ECE2022

Reliability of who fracture risk assessment tool (frax) and bone mineral density in predicting fractures in cancer patients under hormone deprivation therapies: a real-world clinical study

Vena Walter , Piccini Sara , Pedersini Rebecca , Carrone Flaminia , Cosentini Deborah , Zucali Paolo , Torrisi Rosalba , Brunetti Alessandro , Pigni Stella , Maroldi Roberto , Balzarini Luca , Lania Andrea Gerardo , Berruti Alfredo , Berruti Gherardo

Background: Skeletal fragility is an important clinical issue in women with early-stage breast cancer and men with non-metastatic prostate cancer under hormonal hormone deprivation therapies (HDTs). Vertebral fractures (VFs) have been reported in a remarkable number of subjects exposed to HDT especially when the diagnosis of fractures is performed by a radiological and morphometric approach. Notably, prediction of fractures in this clinical setting is a challenge and determina...

ea0099rc10.5 | Rapid Communications 10: Calcium and Bone | Part II | ECE2024

Determinants of vertebral fractures and effectiveness of anti-resorptive drmgs in pre-menopausal women with early breast cancer under hormone deprivation therapies: A multicenter real-world study

Cristofolini Giacomo , Pedersini Rebecca , Palermo Andrea , Vena Walter , Presciuttini Barbara , Birtolo Maria Francesca , Tabacco Gaia , Naciu Anda Mihaela , Pigni Stella , Lagana Marta , Mazzoleni Federica , Cosentini Deborah , Ciafardini Antea , Pagani Mauro , Farina Davide , Balzarini Luca , Zambelli Alberto , Torrisi Rosalba , Cianferotti Luisella , Napoli Nicola , Bossi Antonio Carlo , Berruti Alfredo , Lania Andrea , Mazziotti Gherardo

Management of skeletal fragility in women with early breast cancer (BC) under hormone-deprivation therapies (HDTs) may be a challenge and it is still unknown whether anti-osteoporotic therapies could be active in preventing fractures in pre-menopausal women exposed to HDTs. In this real-world, multicenter study, we evaluated the effectiveness of bone-active drmgs and determinants of vertebral fractures (VFs) in 306 pre-menopausal women (mean age 47.15±5.09, range: 30-54) wi...